Clinical Trial Update: A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection [Phase 1]

View source ↗

Summary

A Phase I study evaluating the safety and tolerability of the Modified Vaccinia Virus Ankara–based HIV vaccine candidate MVA-B in healthy volunteers at low risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MVA-B

Snippet

Sponsor: Juan A. Arnaiz | Conditions: HIV Infections | Phase 1 | Status: COMPLETED